You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Buprenorphine, Naloxone Drug Combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Opioid-use Disorder Trial in New York (Buprenorphine/naloxone, Placebo)

Recruiting
  • Opioid-use Disorder
  • New York, New York
    Stars/Nyspi
Aug 11, 2022

Addiction, Opioid Use, Substance Use Disorders Trial (Placebo, Auvelity)

Not yet recruiting
  • Addiction
  • +3 more
  • (no location specified)
Aug 3, 2023

Opioid-use Disorder, Opioid Dependence, Opioid Overdose Trial in Houston (Buprenorphine, Naloxone Drug Combination, Individual

Recruiting
  • Opioid-use Disorder
  • +4 more
  • Buprenorphine, Naloxone Drug Combination
  • +5 more
  • Houston, Texas
    The University of Texas Health Science Center at Houston
May 17, 2022

Drug Interaction, Analgesics, Opioid Trial in Richmond (Lemborexant, Placebo)

Recruiting
  • Drug Interaction
  • Analgesics, Opioid
  • Richmond, Virginia
    Virginia Commonwealth University
Nov 28, 2022

Maternal Opioid Use Disorder, Opioid Exposed Infant Trial in Baltimore (fetal monitoring, Buprenorphine Naloxone, Methadone)

Recruiting
  • Maternal Opioid Use Disorder
  • Opioid Exposed Infant
  • fetal monitoring
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins Bayview Medical Center
Dec 30, 2022

Opioid Dependence Fentanyl Trial in Harrisburg (Buprenorphine/naloxone)

Recruiting
  • Opioid Dependence Fentanyl
  • Harrisburg, Pennsylvania
    The Pennsylvania Psychiatric Institute
Dec 1, 2022

Opioid-Related Disorders, Substance-Related Disorders, Narcotic-Related Disorders Trial in United States (Injectable

Not yet recruiting
  • Opioid-Related Disorders
  • +2 more
  • Injectable extended-release buprenorphine
  • Sublingual buprenorphine-naloxone
  • Garberville, California
  • +5 more
Aug 28, 2023

Opioid Use Disorder Trial in Overland Park (ASP8062, Placebo ASP8062, buprenorphine/naloxone)

Completed
Has Results
  • Opioid Use Disorder
  • Overland Park, Kansas
    Altasciences Clinical Kansas, Inc.
Dec 14, 2021

Opioid Use Disorder, HIV Trial (medication for opioid use disorder)

Completed
  • Opioid Use Disorder
  • HIV Infections
  • medication for opioid use disorder
  • (no location specified)
May 5, 2022

Immune Activation and Cardiovascular Risk in HIV

Active, not recruiting
  • HIV Infection
  • +2 more
  • Cleveland, Ohio
  • +1 more
Sep 20, 2022

Opioid-Related Disorders, Behavior, Addictive Trial (Adolescent Community Reinforcement Approach (A-CRA), Combination of

Withdrawn
  • Opioid-Related Disorders
  • Behavior, Addictive
  • Adolescent Community Reinforcement Approach (A-CRA)
  • Combination of buprenorphine/naloxone 4/1
  • (no location specified)
Jul 24, 2020

Opioid-use Disorder Trial in Baltimore (Patient Navigation, Buprenorphine)

Enrolling by invitation
  • Opioid-use Disorder
  • Baltimore, Maryland
  • +1 more
Dec 15, 2021

Opioid-use Disorder Trial in Spokane (Reminders messages to improve adherence.)

Completed
  • Opioid-use Disorder
  • Reminders messages to improve adherence.
  • Spokane, Washington
    Washington State University
Jan 26, 2022

Opioid Dependence, Addiction, HIV/AIDS Trial in Kajang (Buprenorphine Naloxone, Methadone, Isoniazid)

Recruiting
  • Opioid Dependence
  • +4 more
  • Buprenorphine Naloxone
  • +3 more
  • Kajang, Selangor, Malaysia
    Kajang Prison
May 18, 2022

Opioid-use Disorder Trial in United States (OXD01 digital therapy, Standard of Care)

Recruiting
  • Opioid-use Disorder
  • OXD01 digital therapy
  • Standard of Care
  • Birmingham, Alabama
  • +20 more
Nov 18, 2022

Opioid Use Disorder Trial in Durham, Raleigh (buprenorphine/naloxone, Pharmacist-administered buprenorphine/naloxone maintenance

Completed
Has Results
  • Opioid Use Disorder
  • Durham, North Carolina
  • +5 more
Jul 26, 2021

Opioid Use Disorder, Opioid Use, Opioid Abuse Trial in Boston (buprenorphine/naloxone)

Not yet recruiting
  • Opioid Use Disorder
  • +4 more
  • Boston, Massachusetts
    Bicycle Health
Nov 30, 2022

Opioid Use Disorder Trial (ASP8062, Placebo ASP8062, buprenorphine/naloxone)

Withdrawn
  • Opioid Use Disorder
  • (no location specified)
Jul 3, 2022

Opioid-use Disorder, Cocaine Use Disorder Trial in Philadelphia (Cariprazine 1.5 MG, Placebo)

Recruiting
  • Opioid-use Disorder
  • Cocaine Use Disorder
  • Cariprazine 1.5 MG
  • Placebo
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 8, 2022

Opioid-use Disorder Trial in New Haven (CBT4CBT-Buprenorphine, Buprenorphine/naloxone)

Completed
  • Opioid-use Disorder
  • New Haven, Connecticut
    Central Medical Unit of the APT Foundation
Jan 2, 2023

Cocaine Dependence Trial in United States (Buprenorphine + Naltrexone, Placebo + Naltrexone)

Completed
Has Results
  • Cocaine Dependence
  • Buprenorphine + Naltrexone
  • Placebo + Naltrexone
  • Los Angeles, California
  • +10 more
Oct 1, 2021

Opioid Use Disorder Trial (buprenorphine/naloxone)

Not yet recruiting
  • Opioid Use Disorder
  • (no location specified)
Jul 10, 2023

Opioid Use Disorder Trial in Vancouver (Buprenorphine/naloxone, Hydromorphone)

Recruiting
  • Opioid Use Disorder
  • Vancouver, British Columbia, Canada
    Vancouver General Hospital
Oct 5, 2022

Opioid Use, Opioid Use Disorder, Risk Reduction Trial in Durham, Greensboro (Suboxone, Truvada, Mavyret)

Active, not recruiting
  • Opioid Use
  • +4 more
  • Durham, North Carolina
  • +1 more
Jan 19, 2023

Opioid Use Disorder Trial in Bronx (buprenorphine-naloxone)

Not yet recruiting
  • Opioid Use Disorder
  • Bronx, New York
    Montefiore Medical Center
Nov 28, 2022